{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T16:32:15Z","timestamp":1747153935063,"version":"3.40.5"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T00:00:00Z","timestamp":1621555200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T00:00:00Z","timestamp":1621555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurosci. Bull."],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s12264-021-00704-w","type":"journal-article","created":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T10:02:42Z","timestamp":1621591362000},"page":"1234-1239","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Inhibition of PI4KIII\u03b1 as a Novel Potential Approach for Gaucher Disease Treatment"],"prefix":"10.1007","volume":"37","author":[{"given":"Linan","family":"Zheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3235-2532","authenticated-orcid":false,"given":"Feng","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fude","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,21]]},"reference":[{"key":"704_CR1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1159\/000440865","volume":"83","author":"A Dandana","year":"2016","unstructured":"Dandana A, Ben Khelifa S, Chahed H, Miled A, Ferchichi S. Gaucher disease: Clinical, biological and therapeutic aspects. Pathobiology 2016, 83: 13\u201323.","journal-title":"Pathobiology"},{"key":"704_CR2","doi-asserted-by":"publisher","first-page":"441","DOI":"10.3390\/ijms18020441","volume":"18","author":"J Stirnemann","year":"2017","unstructured":"Stirnemann J, Belmatoug N, Camou F, Serratrice C, Froissart R, Caillaud C. A review of gaucher disease pathophysiology, clinical presentation and treatments. Int J Mol Sci 2017, 18: 441.","journal-title":"Int J Mol Sci"},{"key":"704_CR3","doi-asserted-by":"publisher","first-page":"2714","DOI":"10.1016\/j.jmb.2020.02.033","volume":"432","author":"F Darios","year":"2020","unstructured":"Darios F, Stevanin G. Impairment of lysosome function and autophagy in rare neurodegenerative diseases. J Mol Biol 2020, 432: 2714\u20132734.","journal-title":"J Mol Biol"},{"key":"704_CR4","doi-asserted-by":"publisher","first-page":"dmm038596","DOI":"10.1242\/dmm.038596","volume":"12","author":"RA Brown","year":"2019","unstructured":"Brown RA, Voit A, Srikanth MP, Thayer JA, Kingsbury TJ, Jacobson MA, et al. mTOR hyperactivity mediates lysosomal dysfunction in Gaucher\u2019s disease iPSC-neuronal cells. Dis Model Mech 2019, 12: dmm038596.","journal-title":"Dis Model Mech"},{"key":"704_CR5","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.3390\/ijms21072576","volume":"21","author":"S Buratta","year":"2020","unstructured":"Buratta S, Tancini B, Sagini K, Delo F, Chiaradia E, Urbanelli L, et al. Lysosomal exocytosis, exosome release and secretory autophagy: The autophagic- and endo-lysosomal systems go extracellular. Int J Mol Sci 2020, 21: 2576.","journal-title":"Int J Mol Sci"},{"key":"704_CR6","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.tcb.2006.05.003","volume":"16","author":"A Balla","year":"2006","unstructured":"Balla A, Balla T. Phosphatidylinositol 4-kinases: Old enzymes with emerging functions. Trends Cell Biol 2006, 16: 351\u2013361.","journal-title":"Trends Cell Biol"},{"key":"704_CR7","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/s12035-012-8358-6","volume":"47","author":"EL Clayton","year":"2013","unstructured":"Clayton EL, Minogue S, Waugh MG. Phosphatidylinositol 4-kinases and PI4P metabolism in the nervous system: Roles in psychiatric and neurological diseases. Mol Neurobiol 2013, 47: 361\u2013372.","journal-title":"Mol Neurobiol"},{"key":"704_CR8","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1021\/bi7017927","volume":"47","author":"A Balla","year":"2008","unstructured":"Balla A, Tuymetova G, Toth B, Szentpetery Z, Zhao X, Knight ZA, et al. Design of drug-resistant alleles of type-III phosphatidylinositol 4-kinases using mutagenesis and molecular modeling. Biochemistry 2008, 47: 1599\u20131607.","journal-title":"Biochemistry"},{"key":"704_CR9","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1097\/WNR.0000000000001348","volume":"31","author":"SJ Mu","year":"2020","unstructured":"Mu SJ, Lim NKH, Huang FD. Inhibition of phosphatidylinositol kinase-III alpha induces or facilitates lysosome exocytosis from microglia. NeuroReport 2020, 31: 697\u2013701.","journal-title":"NeuroReport"},{"key":"704_CR10","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1038\/mt.2016.53","volume":"24","author":"J Marshall","year":"2016","unstructured":"Marshall J, Sun Y, Bangari DS, Budman E, Park H, Nietupski JB, et al. CNS-accessible inhibitor of glucosylceramide synthase for substrate reduction therapy of neuronopathic gaucher disease. Mol Ther 2016, 24: 1019\u20131029.","journal-title":"Mol Ther"},{"key":"704_CR11","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1038\/s41573-019-0036-1","volume":"18","author":"SR Bonam","year":"2019","unstructured":"Bonam SR, Wang F, Muller S. Lysosomes as a therapeutic target. Nat Rev Drug Discov 2019, 18: 923\u2013948.","journal-title":"Nat Rev Drug Discov"},{"key":"704_CR12","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1007\/s12264-018-0313-8","volume":"35","author":"Z Fang","year":"2019","unstructured":"Fang Z, Feng Y, Li Y, Deng J, Nie H, Yang Q, et al. Neuroprotective autophagic flux induced by hyperbaric oxygen preconditioning is mediated by cystatin C. Neurosci Bull 2019, 35: 336\u2013346.","journal-title":"Neurosci Bull"},{"key":"704_CR13","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1007\/s12264-020-00605-4","volume":"36","author":"L Song","year":"2020","unstructured":"Song L, Zhang L. Tau accumulation and defective autophagy: A common pathological mechanism underlying repeat-expansion-induced neurodegenerative diseases?. Neurosci Bull 2020, 36: 1411\u20131413.","journal-title":"Neurosci Bull"},{"key":"704_CR14","doi-asserted-by":"publisher","first-page":"6120","DOI":"10.1074\/jbc.M113.531426","volume":"289","author":"N Bojjireddy","year":"2014","unstructured":"Bojjireddy N, Botyanszki J, Hammond G, Creech D, Peterson R, Kemp DC, et al. Pharmacological and genetic targeting of the PI4KA enzyme reveals its important role in maintaining plasma membrane phosphatidylinositol 4-phosphate and phosphatidylinositol 4, 5-bisphosphate levels. J Biol Chem 2014, 289: 6120\u20136132.","journal-title":"J Biol Chem"}],"container-title":["Neuroscience Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-021-00704-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12264-021-00704-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-021-00704-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T18:48:37Z","timestamp":1628534917000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12264-021-00704-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,21]]},"references-count":14,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["704"],"URL":"https:\/\/doi.org\/10.1007\/s12264-021-00704-w","relation":{},"ISSN":["1673-7067","1995-8218"],"issn-type":[{"type":"print","value":"1673-7067"},{"type":"electronic","value":"1995-8218"}],"subject":[],"published":{"date-parts":[[2021,5,21]]},"assertion":[{"value":"26 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors disclose no relevant conflict of interests with this research.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}